Cancer Screening

Although colorectal cancer is most commonly diagnosed among those aged older than 50 years, we have seen a decrease in cases diagnosed in that age group due to screening and prevention. Unfortunately, the rates of colorectal cancer among those aged younger than 50 years have been rising in the United States, with an estimated 12% of cases, or about 18,000, diagnosed among this younger population in 2020. Recently, the American Cancer Society and the USPSTF lowered the recommended age to begin screening to 45 years.

Prostate cancer screening rates appeared to differ among Black, white, Hispanic and Asian/Pacific Islander men following the 2012 U.S. Preventive Services Task Force recommendation against routine PSA testing, according to study results.

More patients presented with more advanced-stage and aggressive types of breast cancer during the beginning of the COVID-19 pandemic compared with the same period in 2019 across the Kaiser Permanente Northern California health care system.

Patients who underwent lung cancer screening had a significant reduction in mortality associated with the disease, although it came with a “tradeoff” of likely overdiagnosis, according to a recent meta-analysis.

In a systematic review and meta-analysis, researchers found that the overall pooled lung cancer screening adherence rate among adults was 55%, “much lower” than rates reported in large randomized clinical trials.

A predictive model for advanced colorectal neoplasia may help increase colorectal cancer screening adherence, according to a study published in Gut.

The U.S. Preventive Services Task Force released a draft recommendation expanding colorectal cancer screening to adults aged 45 years. It was the top story in hematology/oncology last week.

All adults should begin to get screened for colorectal cancer at age 45 years, according to a draft recommendation by the U.S. Preventive Services Task Force.

Once the leading cause of cancer death among U.S. women, cervical cancer incidence and mortality have decreased substantially over the past 40 years, largely due to screening.

A new study that evaluated the applicability of newer individual risk-based prediction models for lung cancer screening highlights a need for new lung cancer screening methods that focus on population demographics and smoking history.